XML 20 R8.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2023
Cashflow from operating activities      
Interest received $ 5,715 $ 3,277 $ 3,122
Royalty and license income received 175 210 4
Grant and other income 25 137 277
Payment of lease interest (8) (6) (17)
Payments to suppliers, employees and for research & development and intellectual property costs (inclusive of GST) (174,649) (170,559) (130,293)
Taxes paid to US (300)    
Research and development tax incentive scheme credit received in cash 10,398 5,926 6,299
Net cash flows used in operating activities (158,644) (161,015) (120,608)
Cash flow from investing activities:      
Purchase of equipment (13) (33) (22)
Net cash used in investing activities (13) (33) (22)
Cash flows from financing activities:      
Payment of lease liabilities (93) (89) (71)
Proceeds on issue of shares, net of issuance costs 34,809 158,818 81,815
Net proceeds under the DFA   85,000 84,500
Cash received for ordinary shares issued on exercise of investor options 20    
Cash received for ordinary shares issued on exercise of options LTIP 31   1,041
Net cash provided by financing activities 34,767 243,729 167,285
Net (decrease)/increase in cash and cash equivalents (123,890) 82,681 46,655
Effects of exchange rate changes on the balance of cash held in foreign currencies (138) 601 (2,097)
Cash and cash equivalents at beginning of period 172,471 89,189 44,631
Cash and cash equivalents at end of period $ 48,443 $ 172,471 $ 89,189